The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis

@article{Kili2008TheLE,
  title={The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis},
  author={Zeki Mesut Yalin Kiliç and Sedef {\"O} Kuran and M. Ugur Akdogan and Bahattin Çiçek and Dilek Oğuz and Bulent Odemis and Nurgul Sasmaz},
  journal={Advances in Therapy},
  year={2008},
  volume={25},
  pages={190-200}
}
IntroductionIn hepatitis B virus (HBV)-related liver cirrhosis, patients with HBV replication show a higher mortality rate than those without. We aimed to investigate the long-term effects of lamivudine on HBV DNA suppression, Child-Pugh score, and survival in patients with hepatitis Be antigen (HBeAg)-negative liver cirrhosis.MethodsSixty-eight patients (51 male, 17 female) diagnosed with HBV-positive liver cirrhosis, who were monitored by the hepatology and liver transplantation outpatient… CONTINUE READING
BETA